MOLINA ARTURO MD (Chief Medical Officer) sold 21.6% of their position (23.15K shares) of PROTAGONIST THERAPEUTICS, INC on the open market
Open‑market sale worth $1.91M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−13.15K
Price / share
$82.42
Trade value
$1.08M
% of position
Common Stock
Shares
+5K
Price / share
$8.04
Trade value
$40.20K
% of position
Common Stock
Shares
−5K
Price / share
$82.28
Trade value
$411.40K
% of position
Common Stock
Shares
+5K
Price / share
$8.04
Trade value
$40.20K
% of position
Common Stock
Shares
−5K
Price / share
$82.00
Trade value
$410K
% of position
Net shares
−13.15K
Net value
-$1.82M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/23/2026 | S · Sale | −13.15K | $82.42 | $1.08M | 13.5% | 97.27K | 84.11K |
| Common Stock Direct | 1/26/2026 | M · Option Exercise | +5K | $8.04 | $40.20K | 5.9% | 84.11K | 89.11K |
| Common Stock Direct | 1/26/2026 | S · Sale | −5K | $82.28 | $411.40K | 5.6% | 89.11K | 84.11K |
| Common Stock Direct | 1/27/2026 | M · Option Exercise | +5K | $8.04 | $40.20K | 5.9% | 84.11K | 89.11K |
| Common Stock Direct | 1/27/2026 | S · Sale | −5K | $82.00 | $410K | 5.6% | 89.11K | 84.11K |
| Total | −13.15K | -$1.82M | ||||||
Stock Option (right to buy)
Common Stock
5K shares
Shares
−5K
Strike price
8.04
Held after
70.97K
Exercisable
—
Stock Option (right to buy)
Common Stock
5K shares
Shares
−5K
Strike price
8.04
Held after
65.97K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock5K shares | 1/26/2026 | M · Option Exercise | −5K | 8.04 | — | 70.97K |
| Stock Option (right to buy) Direct | Common Stock5K shares | 1/27/2026 | M · Option Exercise | −5K | 8.04 | — | 65.97K |